WHO ICTRP trial

Using light glasses in patients suffering from Multiple Sclerosis-related…

DRKS00036464 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00036464
Public title Using light glasses in patients suffering from Multiple Sclerosis-related fatigue
Scientific title Using light glasses in patients suffering from Multiple Sclerosis-related fatigue - Light glasses in fatigued MS patients
Primary sponsor Universitäres Schlafmedizinisches Zentrum Regensburg am Bezirksklinikum Regensburg
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type interventional
Countries Germany
Conditions Multiple Sclerosis (Encephalomyelitis disseminata), G 35, accompanied by severe fatigue G35;Multiple sclerosis
Interventions Group 1: Placebo (week 1) - washout (week 2) - active condition (week 3); during the placebo week, participants use light glasses emitting dim red (660 nm) light at low illumination levels (150 lux) daily upon wakening for 20 minutes…
Registration date Mar 25, 2025
Target size 30
Secondary IDs 23-3307-101
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations